Synbiotics and Treatment of Asthma: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial.

Background: We examined the efficiency and safety of a specific synbiotic compound, brand name Kidilact, in the treatment of asthma in children 12 years of age or younger.

Materials And Methods: This double-blinded, randomized, placebo-controlled clinical trial was conducted in Tehran, Iran, from May 22, 2016, to May 21, 2017. One hundred children, 12 years of age or younger, who suffered from mild to moderate asthma were recruited in this study.